Unique Clinical Pearl sessions are held throughout the AAPP Annual Meeting. Slide sets for these sessions are made available through the AAPP Communities.
2024 Annual Meeting
- Abelleira A. Home Sweet Home: Operationalizing Low-Dose Buprenorphine Initiations for Virtual Care. [Weblink]
- Allen S. Paternal Postpartum Depression – Identification and Barriers. [Weblink]
- Crouse E. For the First Time in Forever: There’s a New Drug-Drug Interaction with Lithium. [Weblink]
- Maister A. The “Other Booster”: Clozapine Augmentation with Fluvoxamine. [Weblink]
- Mustafa A. Tackling the Treatment of Tardive Dyskinesia. [Weblink]
- Rarrick C. Pearls for Creating a Collaborative Practice Agreement. [Weblink]
2023 Annual Meeting
- Adams K. Clozapine-Induced Gastrointestinal Hypomotility. [Weblink]
- Ferren J. Autoimmune Encephalitis: What Psychiatric Pharmacists Should Know. [Weblink]
- Liveoak K. Xylazine: A New Deadly Threat to Public Health. [Weblink]
- Schwab S. Using Midazolam for Managing Acute Agitation. [Weblink]
- Stutzman D. Aripiprazole for Anorexia Nervosa. [Weblink]
- Thacker E. Beyond Benzos: Treatment of Refractory Catatonia. [Weblink]
2022 Annual Meeting
- Cusimano J. Parkinsonism-hyperpyrexia Syndrome. [Weblink]
- Doroudgar S. Antipsychotic-Induced Hyperprolactinemia: An Approach to Medication Management. [Weblink]
- Liriano C. Clozapine: Removing the Smoke Screen. [Weblink]
Reviewer 1: Claire Herbst, PharmD, BCPS, BCPP
Reviewer 2: Austin Smith, PharmD, BCPP
2024-2025 AAPP Resident and New Practitioner Committee
